AA

Anne-Marie Andersson

CTO

Hervolution Therapeutics

Copenhagen, Capital Region of Denmark


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Hervolution Therapeutics
Industry
research
Employees
22.0
Seniority
C suite
Total Funding
18171720.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Amazon AWS Google Font API Apache Google Tag Manager Varnish Typekit Mobile Friendly WordPress.org Basis Remote AI

Keywords

oncology aging dark genome als diabetes longevity biotechnology research hervs immunotherapy cancer treatment aging-related diseases metabolic disease neurodegenerative diseases immune system activation antigen targeting biotechnology cell-mediated immunity humoral immunity adenoviral vector mrna vector virus-like particles immunogenic antigens immune tolerance clinical trials drug development patient delivery senescence herv-k dual adenoviral therapy immune response induction off-the-shelf therapy prostate cancer pancreatic cancer anti-herv immunity disease targets aging process tumor-specific antigens chronic conditions novel therapies therapeutic pipeline rational design biotech innovation preclinical data herv protein expression tumor immunity drug targets collaboration biotech funding engineered vaccines research publications platform technology scientific advisory board regulatory compliance biotech leadership research collaboration hospital & health care medical health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans